Abstract
Since conventional therapy faces limitations in the field of different cancers as well as gastrointestinal cancers, that decrease the survival rate of patients, there is an urgent need to find new effective therapeutic approaches without the adverse effects of the traditional agents. Antimicrobial peptides (AMPs) attract much attention and are well known for their role in innate immunity. These peptides, in addition to their antimicrobial activity, exhibit strong anticancer potential against various types of malignancy. AMPs specifically target tumor cells and have selective toxicity for these cells without affecting normal cells. Here we aim to comprehensively overview the current knowledge in the field of using AMPs as novel therapeutic agents for gastrointestinal cancer.
Similar content being viewed by others
Data availability
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
Code availability
Not applicable.
References
Alfarouk KO, Stock C-M, Taylor S, Walsh M, Muddathir AK, Verduzco D et al (2015) Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell Int 15(1):1–13
Alsaggar M, Al-Tarawneh A, Al Tall Y, Al-Hazabreh M (2021) SAMA peptide, a rationally designed antimicrobial peptide. J Appl Pharm Sci 12(1):182–189
Ashby M, Petkova A, Gani J, Mikut R, Hilpert K (2017) Use of peptide libraries for identification and optimization of novel antimicrobial peptides. Curr Top Med Chem 17(5):537–553
Bakare OO, Gokul A, Wu R, Niekerk L-A, Klein A, Keyster M (2021) Biomedical relevance of novel anticancer peptides in the sensitive treatment of cancer. Biomolecules 11(8):1120
Burkoth TS, Fafarman AT, Charych DH, Connolly MD, Zuckermann RN (2003) Incorporation of unprotected heterocyclic side chains into peptoid oligomers via solid-phase submonomer synthesis. J Am Chem Soc 125(29):8841–8845
Chen CH, Lu TK (2020) Development and challenges of antimicrobial peptides for therapeutic applications. Antibiotics 9(1):24
Cole AM, Ganz T (2000) Human antimicrobial peptides: analysis and application. Biotechniques 29(4):822–831
Cuevas F, Saavedra CJ, Romero-Estudillo I, Boto A, Ordóñez M, Vergara I (2021) Structural diversity using hyp “customizable units”: proof-of-concept synthesis of sansalvamide-related antitumoral peptides. Eur J Org Chem 2021(6):933–943
Davis MR, Singh EK, Wahyudi H, Alexander LD, Kunicki JB, Nazarova LA et al (2012) Synthesis of sansalvamide A peptidomimetics: triazole, oxazole, thiazole, and pseudoproline containing compounds. Tetrahedron 68(4):1029–1051
Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC et al (2021) New approaches and procedures for cancer treatment: current perspectives. SAGE Open Med 9:20503121211034370
DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL et al (2014) Cancer treatment and survivorship statistics, 2014. CA: Cancer J Clin 64(4):252–71
Deslouches B, Di YP (2017) Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications. Oncotarget 8(28):46635
Fan R, Tong A, Li X, Gao X, Mei L, Zhou L et al (2015) Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer. Int J Nanomed 10:7291
Felício MR, Silva ON, Gonçalves S, Santos NC, Franco OL (2017) Peptides with dual antimicrobial and anticancer activities. Front Chem 5:5
Fischer R, Kohler K, Fotin-Mleczek M, Brock R (2004) A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J Biol Chem 279(13):12625–12635
Galdiero E, Lombardi L, Falanga A, Libralato G, Guida M, Carotenuto R (2019) Biofilms: novel strategies based on antimicrobial peptides. Pharmaceutics 11(7):322
Gaspar D, Veiga AS, Castanho MA (2013) From antimicrobial to anticancer peptides. A review. Front Microbiol 4:294
Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Mirjalili BBF, Bijanzadeh HR (2020a) Structure-activity relationship studies of longicalcynin A analogues, as anticancer cyclopeptides. Chem Biol Interact 315:108902
Gholibeikian M, Bamoniri A, HoushdarTehrani MH, FatemehMirjalili BB, Bijanzadeh HR (2020b) Corrigendum to" Structure-activity relationship studies of longicalcynin A analogues, as anticancer cyclopeptides” "[Chem. Biol. Interact. 315 (2020) 108902, 1-14]. Chem Biol Interact 331:109143
Gottler LM, Ramamoorthy A (2009) Structure, membrane orientation, mechanism, and function of pexiganan—a highly potent antimicrobial peptide designed from magainin. Biochim Biophys Acta (BBA)-Biomembranes 1788(8):1680–1686
Greco I, Molchanova N, Holmedal E, Jenssen H, Hummel BD, Watts JL et al (2020) Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides. Sci Rep 10(1):1–13
Guerra JR, Cárdenas AB, Ochoa-Zarzosa A, Meza JL, Pérez AU, Fierro-Medina R et al (2019) The tetrameric peptide LfcinB (20–25) 4 derived from bovine lactoferricin induces apoptosis in the MCF-7 breast cancer cell line. RSC Adv 9(36):20497–20504
Haley B, Frenkel E (eds) (2008) Nanoparticles for drug delivery in cancer treatment. Urologic oncology: seminars and original investigations. Elsevier
Hoskin DW, Ramamoorthy A (2008) Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta (BBA)-Biomembranes 1778(2):357–75
Hou Y, Liu R, Xia M, Sun C, Zhong B, Yu J et al (2021) Nannocystin ax, an eEF1A inhibitor, induces G1 cell cycle arrest and caspase-independent apoptosis through cyclin D1 downregulation in colon cancer in vivo. Pharmacol Res 173:105870
Huan Y (2020) Antimicrobial peptides: classification, design, application and research progress in multiple fields. Front Microbiol 11:1–21
Jafari A, Babajani A, Sarrami Forooshani R, Yazdani M, Rezaei-Tavirani M (2022) Clinical applications and anticancer effects of antimicrobial peptides: from bench to bedside. Front Oncol 12:350
Jeong Y-J, Choi Y, Shin J-M, Cho H-J, Kang J-H, Park K-K et al (2014) Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells. Food Chem Toxicol 68:218–225
Kemik O, Kemik A, Sumer A, Begenik H, Purisa S, Tuzun S (2013) Human neutrophil peptides 1, 2 and 3 (HNP 1–3): elevated serum levels in colorectal cancer and novel marker of lymphatic and hepatic metastasis. Hum Exp Toxicol 32(2):167–171
Koczulla AR, Bals R (2003) Antimicrobial peptides. Drugs 63(4):389–406
Kong G-M, Tao W-H, Diao Y-L, Fang P-H, Wang J-J, Bo P et al (2016) Melittin induces human gastric cancer cell apoptosis via activation of mitochondrial pathway. World J Gastroenterol 22(11):3186
Koo DJ, Sut TN, Tan SW, Yoon BK, Jackman JA (2022) Biophysical characterization of LTX-315 anticancer peptide interactions with model membrane platforms: effect of membrane surface charge. Int J Mol Sci 23(18):10558
Kościuczuk EM, Lisowski P, Jarczak J, Strzałkowska N, Jóźwik A, Horbańczuk J et al (2012) Cathelicidins: family of antimicrobial peptides. A review. Mol Biol Rep 39(12):10957–10970
Krastel P, Roggo S, Schirle M, Ross NT, Perruccio F, Aspesi P Jr et al (2015) Nannocystin A: an elongation factor 1 inhibitor from myxobacteria with differential anti-cancer properties. Angew Chem Int Ed 54(35):10149–10154
Kumar P, Kizhakkedathu JN, Straus SK (2018) Antimicrobial peptides: diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo. Biomolecules 8(1):4
Kumar R, Ali SA, Singh SK, Bhushan V, Mathur M, Jamwal S et al (2020) Antimicrobial peptides in farm animals: an updated review on its diversity, function, modes of action and therapeutic prospects. Veterinary Sciences 7(4):206
Lee HS, Park CB, Kim JM, Jang SA, Park IY, Kim MS et al (2008) Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide. Cancer Lett 271(1):47–55
Lee H-T, Lee C-C, Yang J-R, Lai JZ, Chang KY (2015) A large-scale structural classification of antimicrobial peptides. BioMed Res Int 2015:1
Lei J, Sun L, Huang S, Zhu C, Li P, He J et al (2019) The antimicrobial peptides and their potential clinical applications. Am J Transl Res 11(7):3919
Li Y, Xiang Q, Zhang Q, Huang Y, Su Z (2012) Overview on the recent study of antimicrobial peptides: origins, functions, relative mechanisms and application. Peptides 37(2):207–215
Liu Q, Yang X, Ji J, Zhang S-L, He Y (2019) Novel nannocystin A analogues as anticancer therapeutics: synthesis, biological evaluations and structure–activity relationship studies. Eur J Med Chem 170:99–111
Liu M, Lai Z, Zhu L, Ding X, Tong X, Wang Z et al (2021) Novel amorphous solid dispersion based on natural deep eutectic solvent for enhancing delivery of anti-tumor RA-XII by oral administration in rats. Eur J Pharm Sci 166:105931
Mader JS, Salsman J, Conrad DM, Hoskin DW (2005) Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol Cancer Ther 4(4):612–624
Maijaroen S, Jangpromma N, Daduang J, Klaynongsruang S (2018) KT2 and RT2 modified antimicrobial peptides derived from crocodylus siamensis leucrocin I show activity against human colon cancer HCT-116 cells. Environ Toxicol Pharmacol 62:164–176
Maraming P, Maijaroen S, Klaynongsruang S, Boonsiri P, Daduang S, Chung J-G et al (2018) Antitumor ability of KT2 peptide derived from leukocyte peptide of Crocodile against human HCT116 colon cancer xenografts. In Vivo 32(5):1137–44
Maraming P, Klaynongsruang S, Boonsiri P, Peng SF, Daduang S, Leelayuwat C et al (2019) The cationic cell-penetrating KT2 peptide promotes cell membrane defects and apoptosis with autophagy inhibition in human HCT 116 colon cancer cells. J Cell Physiol 234(12):22116–22129
Marsh D, Jost M, Peggion C, Toniolo C (2007) TOAC spin labels in the backbone of alamethicin: EPR studies in lipid membranes. Biophys J 92(2):473–481
Meng L, Xu G, Li J, Liu W, Jia W, Ma J et al (2017) Bovine lactoferricin P13 triggers ROS-mediated caspase-dependent apoptosis in SMMC7721 cells. Oncol Lett 13(1):511–517
Moon D-O, Park S-Y, Choi YH, Kim ND, Lee C, Kim G-Y (2008) Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells. Toxicon 51(1):112–120
Moore A (2003) The big and small of drug discovery: Biotech versus pharma: advantages and drawbacks in drug development. EMBO Rep 4(2):114–117
Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T et al (2022) The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study. EClinicalMedicine 47:101404
Niyonsaba F, Kiatsurayanon C, Chieosilapatham P, Ogawa H (2017) Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases. Exp Dermatol 26(11):989–998
Nomula R, Pratapure MS, Kontham R (2022) Studies directed toward the total synthesis of nannocystin A. ChemistrySelect 7(42):e202203893
Norouzi Z, Salimi A, Halabian R, Fahimi H (2018) Nisin, a potent bacteriocin and anti-bacterial peptide, attenuates expression of metastatic genes in colorectal cancer cell lines. Microb Pathog 123:183–189
Pan W-R, Chen P-W, Chen Y-L, Hsu H-C, Lin C-C, Chen W-J (2013) Bovine lactoferricin B induces apoptosis of human gastric cancer cell line AGS by inhibition of autophagy at a late stage. J Dairy Sci 96(12):7511–7520
Panjeta A, Preet S (2020) Anticancer potential of human intestinal defensin 5 against 1, 2-dimethylhydrazine dihydrochloride induced colon cancer: a therapeutic approach. Peptides 126:170263
Park CB, Yi K-S, Matsuzaki K, Kim MS, Kim SC (2000) Structure–activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc Natl Acad Sci 97(15):8245-50
Poock C, Kalesse M (2017) Total synthesis of nannocystin Ax. Org Lett 19(17):4536–4539
Ren SX, Cheng AS, To KF, Tong JH, Li MS, Shen J et al (2012) Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancerLL-37 induces AIF-and EndoG-mediated cell death. Can Res 72(24):6512–6523
Ridyard KE, Overhage J (2021) The potential of human peptide LL-37 as an antimicrobial and anti-biofilm agent. Antibiotics 10(6):650
Riool M, de Breij A, Drijfhout JW, Nibbering PH, Zaat SA (2017) Antimicrobial peptides in biomedical device manufacturing. Front Chem 5:63
Rodriguez RA, Pan P-S, Pan C-M, Ravula S, Lapera S, Singh EK et al (2007) Synthesis of second-generation sansalvamide A derivatives: novel templates as potential antitumor agents. J Org Chem 72(6):1980–2002
Roudi R, Syn NL, Roudbary M (2017) Antimicrobial peptides as biologic and immunotherapeutic agents against cancer: a comprehensive overview. Front Immunol 8:1320
Sadat SM, Jahan ST, Haddadi A (2016) Effects of size and surface charge of polymeric nanoparticles on in vitro and in vivo applications. J Biomater Nanobiotechnol 7(02):91
Sancho-Vaello E, Gil-Carton D, François P, Bonetti E-J, Kreir M, Pothula KR et al (2020) The structure of the antimicrobial human cathelicidin LL-37 shows oligomerization and channel formation in the presence of membrane mimics. Sci Rep 10(1):1–16
Shin J-M, Jeong Y-J, Cho H-J, Park K-K, Chung I-K, Lee I-K et al (2013) Melittin suppresses HIF-1α/VEGF expression through inhibition of ERK and mTOR/p70S6K pathway in human cervical carcinoma cells. PLoS ONE 8(7):e69380
Slaninová J, Mlsová V, Kroupová H, Alán L, Tůmová T, Monincová L et al (2012) Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells. Peptides 33(1):18–26
Son S, Jang M, Lee B, Hong Y-S, Ko S-K, Jang J-H et al (2018) Ulleungdin, a lasso peptide with cancer cell migration inhibitory activity discovered by the genome mining approach. J Nat Prod 81(10):2205–2211
Spiliopoulos S, Festas G, Reppas L, Brountzos E (2019) Intra-arterial administration of cell-based biological agents for ischemic stroke therapy. Expert Opin Biol Ther 19(3):249–259
Steichen SD, Caldorera-Moore M, Peppas NA (2013) A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci 48(3):416–427
Sudheendra U, Dhople V, Datta A, Kar RK, Shelburne CE, Bhunia A et al (2015) Membrane disruptive antimicrobial activities of human β-defensin-3 analogs. Eur J Med Chem 91:91–99
Sun L, Zheng C, Webster TJ (2017) Self-assembled peptide nanomaterials for biomedical applications: promises and pitfalls. Int J Nanomed 12:73
Tan M, Liao C, Liang L, Yi X, Zhou Z, Wei G (2022) Recent advances in recombinase polymerase amplification: principle, advantages, disadvantages and applications. Front Cell Infect Microbiol 12:1744
Tian Y, Xu X, Ding Y, Hao X, Bai Y, Tang Y et al (2018) Synthesis and biological evaluation of nannocystin analogues toward understanding the binding role of the (2R, 3S)-Epoxide in nannocystin A. Eur J Med Chem 150:626–632
Torchilin VP, Lukyanov AN (2003) Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discov Today 8(6):259–266
Umerska A, Cassisa V, Bastiat G, Matougui N, Nehme H, Manero F et al (2017) Synergistic interactions between antimicrobial peptides derived from plectasin and lipid nanocapsules containing monolaurin as a cosurfactant against Staphylococcus aureus. Int J Nanomed 12:5687
Vandamme D, Landuyt B, Luyten W, Schoofs L (2012) A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol 280(1):22–35
Veldhuizen EJ, Schneider VA, Agustiandari H, Van Dijk A, Tjeerdsma-van Bokhoven JL, Bikker FJ et al (2014) Antimicrobial and immunomodulatory activities of PR-39 derived peptides. PLoS ONE 9(4):e95939
Wang G (2012) Post-translational modifications of natural antimicrobial peptides and strategies for peptide engineering. Current Biotechnology 1(1):72–79
Wang G, Narayana JL, Mishra B, Zhang Y, Wang F, Wang C, et al (2019b) Design of antimicrobial peptides: progress made with human cathelicidin LL-37. Antimicrobial Peptides 215–40. https://link.springer.com/chapter/10.1007/978-981-13-3588-4_12
Wang L, Hu C, Shao L (2017) The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomed 12:1227
Wang X, Zhang J, Wu H, Li Y, Conti PS, Chen K (2018) PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric sansalvamide A decapeptide. Amino Acids 50(7):897–907
Wang Y, Guo D, He J, Song L, Chen H, Zhang Z et al (2019a) Inhibition of fatty acid synthesis arrests colorectal neoplasm growth and metastasis: anti-cancer therapeutical effects of natural cyclopeptide RA-XII. Biochem Biophys Res Commun 512(4):819–824
Wang C, Chen T, Zhang N, Yang M, Li B, Lü X et al (2021) Withdrawal: melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting IκBα kinase-NFκB. J Biol Chem 296:100767
Wang J, Wang J, Li L, Feng L, Wang Y-R, Wang Z et al (2021) RA-XII, a bicyclic hexapeptidic glucoside isolated from Rubia yunnanensis Diels, exerts antitumor activity by inhibiting protective autophagy and activating Akt-mTOR pathway in colorectal cancer cells. J Ethnopharmacol 266:113438
Wang X, Zhang J, Han Z, Ma L, Li Y (2022) 18F-labeled dimer-sansalvamide A cyclodecapeptide: a novel diagnostic probe to discriminate pancreatic cancer from inflammation in a nude mice model. J Cancer 13(6):1848
Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci 97(24):13003-8
Wu X, Zhao B, Cheng Y, Yang Y, Huang C, Meng X et al (2015) Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cells. Toxicol Appl Pharmacol 288(1):74–83
Wu Z, Ding Z, Cheng B, Cui Z (2021) The inhibitory effect of human DEFA5 in growth of gastric cancer by targeting BMI1. Cancer Sci 112(3):1075–1083
Xi Y, Xu P (2021) Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 14(10):101174
Xia Y, Wei J, Zhao S, Guo B, Meng F, Klumperman B et al (2021) Systemic administration of polymersomal oncolytic peptide LTX-315 combining with CpG adjuvant and anti-PD-1 antibody boosts immunotherapy of melanoma. J Control Release 336:262–273
Xia C, Dong X, Li H, Cao M, Sun D, He S et al (2022) Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J 135(05):584–590
Xie M, Liu D, Yang Y (2020) Anti-cancer peptides: classification, mechanism of action, reconstruction and modification. Open Biol 10(7):200004
Xu Y, Yao Y, Wang L, Chen H, Tan N (2021) Hyaluronic acid coated liposomes Co-delivery of natural cyclic peptide RA-XII and mitochondrial targeted photosensitizer for highly selective precise combined treatment of colon cancer. Int J Nanomed 16:4929
Yamazaki T, Wennerberg E, Hensler M, Buqué A, Kraynak J, Fucikova J et al (2021) LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. Oncoimmunology 10(1):1962592
Zanetti M (2005) The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol 7(2):179–196
Zelezetsky I, Tossi A (2006) Alpha-helical antimicrobial peptides—using a sequence template to guide structure–activity relationship studies. Biochim Biophys Acta (BBA)-Biomembranes 1758(9):1436–49
Zhang Y, Xu X, Zhang M, Wang X, Bai X, Li H et al (2016) MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD. BMC Cancer 16(1):1–10
Zhang S-K, Song J-w, Gong F, Li S-B, Chang H-Y, Xie H-M et al (2016) Design of an α-helical antimicrobial peptide with improved cell-selective and potent anti-biofilm activity. Sci Rep 6(1):1–13
Zhang C, Yang M, Ericsson AC (2019) Antimicrobial peptides: potential application in liver cancer. Front Microbiol 10:1257
Zhang H, Zhen J, Zhang R, Wanyan Y, Liu K, Yuan X et al (2022) Cathelicidin hCAP18/LL-37 promotes cell proliferation and suppresses antitumor activity of 1, 25 (OH) 2D3 in hepatocellular carcinoma. Cell Death Discovery 8(1):1–13
Zhou J, Liu Y, Shen T, Chen L, Zhang C, Cai K et al (2019) Antimicrobial activity of the antibacterial peptide PMAP-36 and its analogues. Microb Pathog 136:103712
Author information
Authors and Affiliations
Contributions
The first draft of the manuscript was written by X.Y., and L.L. and Z.G. commented and improved the manuscript. All authors collaborated and commented on previous versions of the manuscript. Finally, all authors read and approved the final manuscript. C.H, L.L. and Z.G. were responsible for coordinating the authors, finalized and submitted the paper. The authors confirm that no paper mill and artificial intelligence was used.
Corresponding author
Ethics declarations
Ethics approval
Ethics approval for this type of article (a review) is not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yang, X., Hua, C., Lin, L. et al. Antimicrobial peptides as potential therapy for gastrointestinal cancers. Naunyn-Schmiedeberg's Arch Pharmacol 396, 2831–2841 (2023). https://doi.org/10.1007/s00210-023-02536-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-023-02536-z